Debridement and primary closure of a mesenteric duodenal perforation in a dog.

A 7-year-old male mixed intact breed dog was presented with a 6-day history of lethargy and anorexia. A linear foreign body was diagnosed and an exploratory laparotomy performed. The foreign body was pushed orad and removed via gastrotomy. Two mesenteric duodenal perforations were found: one at the level of the common bile duct and a second at the duodenal flexure. Both lesions were debrided and primarily closed in a simple interrupted appositional pattern. A gastrostomy tube and closed suction drain were placed routinely. The dog recovered without complications and ate voluntarily the first day postoperatively. The drain and gastrostomy tube were removed without incident at 4 and 15 days, respectively. Five months postoperatively the dog was reported to be clinically normal. Debridement and primary closure may represent an alternative to more extensive surgery with rerouting for duodenal perforations in select cases.

Initial exploration of the discriminatory ability of the PetPace collar to detect differences in activity and physiological variables between healthy and osteoarthritic dogs.

Background: Accelerometry has been used to evaluate activity in dogs with osteoarthritis (OA) pain, especially in relation to effect of treatment; however no studies have compared accelerometry-measured activity in dogs with OA-pain and healthy dogs. The aims of this study were to (1) compare activity output from the PetPace collar with the validated Actical monitor and (2) determine if PetPace collar outputs (overall activity, activity levels, body position, and vital signs) differed between healthy dogs and dogs with OA-pain. Methods: This was an observational, non-interventional study in healthy dogs and dogs with OA-pain. All dogs were outfitted with the PetPace collar and the Actical monitor simultaneously for 14 days. Output from these devices was compared (correlations), and output from the PetPace device was used to explore differences between groups across the activity and vital sign outputs (including calculated heart rate variability indices). Results: There was moderate correlation between the PetPace collar and Actical monitor output (R 2 = 0.56, p < 0.001). Using data generated by the PetPace collar, OA-pain dogs had lower overall activity counts and spent less time standing than healthy dogs. Healthy dogs spent more time at higher activity levels than OA-pain dogs. Certain heart rate variability indices in OA-pain dogs were lower than in healthy dogs. Conclusions and clinical relevance: The results of this study suggest that the PetPace collar can detect differences between healthy dogs and those with OA-pain, and that OA-pain negatively impacts overall activity levels in dogs, and especially higher intensity activity.

Pharmacokinetic and safety assessment of carboplatin-impregnated calcium sulfate hemihydrate beads in eight rats.

OBJECTIVE: Evaluate local tissue toxicity and plasma platinum (Pt) in vivo after subcutaneous implantation of carboplatin-impregnated calcium sulfate hemihydrate (CI-CSH) beads. STUDY DESIGN: In vivo experimental study. ANIMALS: Eight male Sprague-Dawley rats. METHODS: CI-CSH beads were implanted subcutaneously (5 mg carboplatin/rat; 13.5 mg/kg carboplatin; 7.08 mg/kg Pt; 1.18 mg/m2 Pt) in eight rats (d0). Wound healing (daily), radiographic bead dissolution (weekly), systemic Pt uptake (plasma-Pt), local tissue Pt (d28), and histologic changes compared to nonincised and incised catheterization sites (d28) were assessed. Blood and tissue samples were analyzed by inductively coupled plasma mass spectrometry for Pt, and pharmacokinetic analysis was performed using noncompartmental methods. RESULTS: One rat died at d10, the remainder survived until d28. No wound complications were seen. The CI-CSH implantation site had higher histopathology scores than the other sites for necrosis (p = .013) and fibrosis (p = .013). Beads decreased in density radiographically (d0 to d28) (p = .062). Peak plasma-Pt concentration was 225.78 ng/ml at 12 h, and decreased over time, but Pt was still detectable on d28. The elimination half-life was 5.03 ± 1.13 days. Only 1.69% of implanted Pt remained in the beads at d28. CONCLUSIONS: CI-CSH beads incited microscopic mild inflammation but wound healing was not impaired. Pt was absorbed systemically and the release from the beads was near complete at d28. CLINICAL SIGNIFICANCE: Piled CI-CSH bead implantation is well tolerated in rats with similar elution profile as previously described. Beads were radiographically visible at d28. Minimal Pt was detected systemically suggesting Pt release does not match bead dissolution.

[Food habits in the Galician population during confinement byCOVID-19]. / Hábitos alimentarios en la poblacion gallega durante el confinamiento por la COVID-19.

INTRODUCTION: Introduction: during the COVID-19 crisis food habits have changed among the population as food consumption is now carried out totally at home, and visits to groceries or food centers have decreased considerably. Likewise, other habits, such as physical activity or sleeping hours have also been modified. Objectives: the objective of this work was to evaluate the changes occurred in eating and lifestyle habits among the adult Galician population during the confinement period ordered in Spain during the COVID-19 pandemic. Methods: a survey was conducted using Microsoft Forms, and spread among the population using an instant messaging service for mobiles through the internet. Results: a total of 1350 Galician adults completed the questionnaire; mean of age was 63.2 ± 8.1 years, 30 % were men, and 70 % were women. The obtained data show a trend towards consumption of healthy foods such as fruits and vegetables, and a decrease in less healthy ones such as processed foods. In total, 46 % of the population reported they were eating more than before the confinement, with an increase in snacking between meals (54 %) and in anxiety about food due to situations of stress or nervousness bieng reported by 40 % of respondents. This has resulted in an increase in body weight, reported by 44 % of participants, with the average gain being 2.8 ± 1.5 kg. Conclusions: during confinement, the eating and lifestyle habits of the Galician population have been modified. The weight gain observed in a population that already had a high level of overweight and obesity at confinement onset aggravates the present situation and may have a negative impact on the development of chronic, non-communicable.

INTRODUCCIÓN: Introducción: en plena crisis por la COVID-19, el consumo alimentario ha pasado a llevarse a cabo en su totalidad en el hogar y las visitas a los centros de distribución de alimentos se han visto reducidas. Asimismo, otros hábitos, como la práctica de ejercicio físico o las horas de sueño, se han visto también modificadas. Objetivos: el objetivo de este trabajo ha sido evaluar los cambios producidos en los hábitos alimentarios y en el estilo de vida de la población gallega durante el período de confinamiento por la COVID-19. Métodos: se elaboró una encuesta en Microsoft Forms para adultos residentes en Galicia y se distribuyó, de manera aleatoria, a través de un servicio de mensajería instantánea para móviles a través de Internet. Resultados: el número de participantes fue de 1350 personas, mayores de edad, siendo el promedio de edad de 63,2 ± 8,1 años y estando la muestra compuesta por un 30 % de hombres y un 70 % de mujeres. Los datos muestran una tendencia hacia el consumo de alimentos saludables, como frutas y verduras, y un descenso de otros menos saludables, como son los alimentos procesados. Un 46 % de la población indicó estar comiendo más que antes del confinamiento, aumentando el picoteo entre horas (54 %) y la ansiedad por la comida, debido a situaciones de estrés o nervios, en un 40 % de los encuestados. Esto se ha traducido en un incremento del peso corporal, indicado por un 44 % de la muestra, siendo la media de kilos ganada de 2,8 ± 1,5. Conclusiones: durante el confinamiento, los hábitos alimentarios y el estilo de vida de la población gallega se han visto modificados. El incremento de peso experimentado en una población que ya partía de un elevado porcentaje de sobrepeso y obesidad al inicio del confinamiento podría tener un impacto negativo en el desarrollo de patologías crónicas no transmisibles.

Sinonasal aspergillosis: Outcome after topical treatment in dogs with cribriform plate lysis.

BACKGROUND: Cribriform lysis has been considered a contraindication for topical treatment of sinonasal aspergillosis (SNA) because of concerns about drug extravasation with resultant neurologic signs or death. OBJECTIVE/HYPOTHESIS: To describe dogs with SNA and cribriform plate lysis treated with topical antifungal medications. Our hypothesis was that the conventional dogma that topical therapy should be avoided in these cases is incorrect. ANIMALS: Nine client-owned dogs with SNA and lysis of the cribriform plate, lysis of the floor of a frontal sinus or both detected by computed tomography (CT). METHODS: A retrospective review of medical records was performed. Dogs that met inclusion criteria (ie, SNA confirmed by at least 1 laboratory test, braincase affected on CT, and topical treatment applied) were included. Size of lesions, ancillary diagnostic test results, topical therapy, and adjuvant PO treatments were recorded. Outcome was determined by phone calls. RESULTS: Four dogs were alive at the time of the manuscript submission with follow-up ranging from 188 to 684 days without neurological signs observed. All dogs were discharged without major complication 1-7 days postoperatively. One dog that had presented with a history of seizures experienced seizure activity 2 months after treatment. CONCLUSIONS AND CLINICAL IMPORTANCE: Topical therapy did not result in complications in these dogs in which lytic regions as large as 16 × 22 mm2 were noted. Sinonasal aspergillosis associated lysis of the cribriform plate; lysis of the floor of a frontal sinus or both detected on CT is not necessarily a contraindication to topical therapy.

A Confirmatory Method Based on HPLC-MS/MS for the Detection and Quantification of Residue of Tetracyclines in Nonmedicated Feed.

The Commission Regulation 574/2011/EC set up maximum levels of coccidiostats and histomonostats in nonmedicated feed as a consequence of carry-over during manufacturing. Carry-over takes place from medicated to nonmedicated feed during feed production. Similar contamination could also occur for other pharmaceuticals such as tetracyclines, a group of antibiotics commonly employed in food production animal. The objective of this work is to present a simple and fast method for the simultaneous detection of four tetracyclines (chlortetracycline, doxycycline, oxytetracycline, and tetracycline) in nontarget feed at a µg/kg level. Validation of the method was performed according to the guideline included in the Commission Decision 2002/657/EC for official method. The validated method was successfully applied to 50 feed samples collected from different milk farms and 25 samples obtained from feed manufacturers. While oxytetracycline was the tetracycline most frequently detected, chlortetracycline was the analyte measured at the highest concentration 15.14 mg/Kg. From 75 nonmedicated feed analysed 15% resulted to be positive for the presence of one tetracycline.

Analysis of Tetracyclines in Medicated Feed for Food Animal Production by HPLC-MS/MS.

The use of medicated feed is a common practice in animal food production to improve animal health. Tetracyclines and ß-Lactams are the groups that are most frequently added to this type of feed. The measurement of the concentration of the analytes in these types of samples is sometimes due to the matrix characteristic, and manufacturers are demanding fast, precise and reproducible methods. A rapid confirmatory method based on a simple extraction protocol using acidified methanol and followed by high performance liquid chromatography coupled to a tandem mass spectrometer for the quantification of four tetracyclines in feed is presented. Validation was performed following the guidelines of Decision 2002/657/EC. Results indicated that the four tetracyclines can be identified and quantified in a concentration range between 50 and 500 mg/kg with recoveries between 84% and 109% and RSD for precision under reproducible conditions between 12% and 16%. Satisfactory results were also obtained with interlaboratory studies and by comparing the method with an HPLC-Fluorescent method.

Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy.

OBJECTIVE: To describe cases of cervical or interstitial ectopic pregnancy managed conservatively with combined medical treatment (methotrexate and mifepristone) alone or in association with other minimally invasive strategies. STUDY DESIGN: We describe four cervical and two interstitial ectopic pregnancies at our hospital between 2006 and 2010. All received combined treatment with methotrexate and mifepristone. A search of MEDLINE is also described. RESULTS: The literature search identified only four previous cases of cervical ectopic pregnancies and no cases of interstitial ectopic pregnancy managed with combined therapy. In our study, all patients were successfully treated and had no adverse reactions with intramuscular methotrexate 50 mg/m² and oral mifepristone 600 mg, either alone or in association with minimally invasive treatment (uterine artery embolization and evacuation dilation and curettage). All patients remained asymptomatic with ß-HCG levels that decreased and became negative within 14-49 days: the median hospital stay was 5.5 days. We also describe the first patient with a cervical ectopic pregnancy treated with methotrexate and mifepristone, followed by vaginal misoprostol 800 mcg for cervical evacuation. CONCLUSION: Methotrexate-mifepristone, either alone or in combination with other minimally invasive strategies, could be considered an option for the treatment of both cervical and interstitial ectopic pregnancy. An individualized approach should be used in each patient, however, given the wide variety of possible clinical situations and the potential seriousness of ectopic pregnancy.